TolerogenixX: Tolerogenixx accepts seed round
The spinout of Heidelberg University Hospital has collected capital from High-Tech Gründerfonds.
Read full article »
TolerogenixX is a Germany-based biopharmaceutical company that discovers and develops personalized cellular therapies for the treatment of autoimmune diseases.
Read more